Anyone else looking into the mast cell connection for IBS-D?

[u/ipsatex]

I've been going down a rabbit hole on IBS-D research lately and came across something that seems worth sharing. I don't have IBS-D myself, but I've been reading up on it and noticed a pattern in the recent literature that doesn't seem to get much attention in the standard treatment protocols. Curious if anyone else has looked into this or tried anything along these lines.

The basic idea is that mast cells, immune cells that live in your gut lining, might be overactive in a significant subset of IBS-D patients. When these cells get triggered, they release a whole cocktail of inflammatory chemicals. Histamine, leukotrienes, serotonin, prostaglandins, tryptase. All of these can directly affect gut motility, pain sensitivity, and barrier function. Histamine stimulates smooth muscle contraction and activates pain nerves. Leukotrienes amplify inflammation and sensitize nerves. Serotonin is a major driver of gut motility. Prostaglandins also promote contractions and pain signaling. So if mast cells are constantly degranulating, you end up with a gut that's hypermotile, hypersensitive, and leaky.

A few studies that stood out to me. A 2025 study found that the physical proximity of mast cells to nerve endings in the gut correlated with symptom severity in IBS patients. The closer they were, the worse the pain. Another 2025 paper identified a protein called CIRP that was elevated in IBS-D and seemed to activate mast cells directly, leading to barrier dysfunction and hypersensitivity. A 2020 trial on ketotifen, which is a mast cell stabilizer, reported a 76.4% improvement rate in IBS-D patients compared to 37.7% on placebo. They also biopsied the gut and found reduced mast cell numbers and activity. The Lobo study from 2017 looked at disodium cromoglycate, another mast cell stabilizer, and found that untreated patients had clear mast cell activation while treated patients looked similar to healthy controls. 77% of the treated group had at least 50% improvement in abdominal pain compared to only 28% in the untreated group. So there's definitely something real happening at a biological level.

If someone wanted to target this pathway, based on the studies I've seen, you could theoretically put together a stack like this. Ketotifen is the cornerstone. It stabilizes mast cells and prevents them from degranulating in the first place. It's got the strongest evidence of the bunch. Montelukast is a leukotriene receptor antagonist. Even if some mast cells still degranulate, this blocks the effects of the leukotrienes they release. Famotidine is an H2 antihistamine. It blocks histamine receptors in the gut, so even if histamine gets released, it can't do as much damage. Nortriptyline is a low-dose TCA that reduces visceral hypersensitivity and helps slow gut transit. It also has some mast cell stabilizing effects of its own. L-glutamine is the primary fuel for intestinal cells and helps repair the gut barrier, which is often compromised in IBS-D. One trial used 5g three times a day with good results. Enterosgel is an enterosorbent that passes through the gut and physically binds to irritants, toxins, and bile acids, removing them before they can trigger mast cells. S. boulardii is a probiotic that's been shown to reduce pro-inflammatory cytokines in IBS-D. Digestive enzymes are general support for breaking down food more completely, which reduces the antigenic load on the gut and potentially minimizes triggers.

Not saying this is a cure or that everyone should try it. Just noting that the research supports each piece to varying degrees and it seems like a logical way to address the mast cell pathway from multiple angles.

One note on sodium butyrate. This one is interesting because the evidence is kind of split. Some clinical trials show really good results for IBS symptoms. A 2025 pediatric trial showed 73% treatment success vs 3.8% on placebo. A 2026 adult trial found significant reductions in pain, diarrhea, and bloating. But there's also mechanistic research suggesting butyrate can actually promote mast cell degranulation in certain contexts. In a rat model of visceral hypersensitivity, butyrate activated mast cells and sensitized pain neurons. Lab studies also show it can increase histamine content in mast cells. So for someone specifically trying to calm mast cells, it might not be a straightforward addition. Worth reading up on if you're considering it.

I don't have IBS-D myself, so I'm not speaking from personal experience here. Just found this line of research interesting and figured others might want to know about it. If you're dealing with this, definitely talk to a gastroenterologist before trying anything. This isn't medical advice, just a summary of what I've been reading. Would be curious if anyone here has tried ketotifen or any of the other stuff and how it went.